N-CARBAMOYL NITROGEN-CONTAINING FUSED RING COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT
申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1475368A1
公开(公告)日:2004-11-10
The present invention relates to the compound presented by formula (I)
(wherein all symbols in formula (I) are the same mean as the description shown in the specification.), mitocondorial benzogeazepin receptor (MBR) antagonist comprising the compound, the preventive and/or treatment medicine against diseases caused by stress of which an active ingredient is the compound.
Since the compound represented by formula (I) has MBR antagonistic activity, and controls the production of neurosteroid, it is useful as the preventive and/or treatment medicine against diseases caused by stress.
本发明涉及由式(I)表示的化合物(式(I)中的所有符号与说明书中的描述相同。
(其中式(I)中的所有符号与说明书中的描述含义相同。)、由该化合物组成的丝裂原苯并氮杂卓受体(MBR)拮抗剂、预防和/或治疗由压力引起的疾病的药物,其有效成分为该化合物。
由于式 (I) 所代表的化合物具有 MBR 拮抗活性,并能控制神经类固醇的产生,因此可用作预防和/或治疗由压力引起的疾病的药物。